Caris Life Sciences Unveils AI Test for Breast Cancer Recurrence
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology NSCLC Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
IRVING, Texas, May 5, 2026 Caris Life Sciences has announced the launch of Caris MI Clarity™, an advanced AI-powered...
SAN DIEGO, May 6, 2026 Gallant, an emerging animal health biotechnology company focused on regenerative veterinary medicine, has announced...
TEANECK, N.J., October 9, 2025 — Phibro Animal Health Corporation (NASDAQ: PAHC) announced a licensing agreement with Lighthouse Pharmaceuticals,...
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
